Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Schnedl, C; Pieber, TR; Amrein, K.
Vitamin D intervention trials in critical illness.
Inflamm Allergy Drug Targets. 2013; 12(4):282-287
Doi: 10.2174/18715281113129990043
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Schnedl Christian
- Co-authors Med Uni Graz
-
Amrein Karin
-
Pieber Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Vitamin D deficiency is common in critically ill patients and has been associated with adverse outcomes. Although many interesting observational studies have been published, only four small randomized controlled trials have been conducted in this vulnerable population. Endpoints included bone turnover, inflammatory markers and safety/efficacy issues. However, all of these trials were underpowered to detect clinically relevant endpoints due to their small sample size. Therefore, future studies focusing on morbidity and mortality endpoints are necessary in order to clarify whether vitamin D deficiency is only a surrogate marker for disease severity or whether treatment with sufficiently large doses of vitamin D may improve patient outcome in an intensive care setting.
- Find related publications in this database (using NLM MeSH Indexing)
-
Critical Illness - mortality
-
Humans -
-
Intensive Care -
-
Randomized Controlled Trials as Topic -
-
Vitamin D - administration & dosage
-
Vitamin D Deficiency - complications